Citations (102)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Jianhua Gu, Feifan He, Gary M Clifford, Minjuan Li, Zhiyuan Fan, Xinqing Li, Shaoming Wang & Wenqiang Wei. (2023) A systematic review and meta-analysis on the relative and attributable risk of Helicobacter pylori infection and cardia and non-cardia gastric cancer. Expert Review of Molecular Diagnostics 23:12, pages 1251-1261.
Read now
Read now
John David Chetwood, Priya Garg, Peter Finch & Melita Gordon. (2019) Systematic review: the etiology of esophageal squamous cell carcinoma in low-income settings. Expert Review of Gastroenterology & Hepatology 13:1, pages 71-88.
Read now
Read now
Per C. Valle, Ragnar K. Breckan, Anil Amin, Magnhild Gangsøy Kristiansen, Einar Husebye, Kåre Nordgård, Liisa Mortensen, Odd A. Kildahl-Andersen & Anna M. Wessel-Berg. (2006) “Test, score and scope”: A selection strategy for safe reduction of upper gastrointestinal endoscopies in young dyspeptic patients referred from primary care. Scandinavian Journal of Gastroenterology 41:2, pages 161-169.
Read now
Read now
J. H. Simán, A. Forsgren, G. Berglund, C.-H. Florén. (2001) Tobacco Smoking Increases the Risk for Gastric Adenocarcinoma among Helicobacter pylori-infected Individuals. Scandinavian Journal of Gastroenterology 36:2, pages 208-213.
Read now
Read now
Articles from other publishers (98)
Maged T. Elghannam, Moataz H. Hassanien, Yosry A. Ameen, Emad A. Turky, Gamal M. ELattar, Ahmed A. ELRay & Mohammed D. ELTalkawy. (2023) Helicobacter pylori and oral–gut microbiome: clinical implications. Infection 52:2, pages 289-300.
Crossref
Crossref
Mohd Aman Mohd Ateeq, Mayur Aalhate, Srushti Mahajan, Ujala Gupta, Indrani Maji, Kedar Khaparkhuntikar, Anish Dhuri, Namitha Mohan C.Saurabh Srivastava & Pankaj Kumar Singh. 2024. Multifunctional Nanocomposites for Targeted Drug Delivery in Cancer Therapy. Multifunctional Nanocomposites for Targeted Drug Delivery in Cancer Therapy
257
302
.
Amanda D. Morgan, Kevin D. Seely, Lauren D. Hagenstein, Garrett M. Florey & James M. Small. (2022) Bacterial Involvement in Progression and Metastasis of Adenocarcinoma of the Stomach. Cancers 14:19, pages 4886.
Crossref
Crossref
Fadoua El Hafa, Tianpei Wang, Valerie Mbuhnwi Ndifor & Guangfu Jin. (2022)
Association between
Helicobacter pylori
antibodies determined by multiplex serology and gastric cancer risk: A meta‐analysis
. Helicobacter 27:3.
Crossref
Crossref
Yong Lu, Fei Xiao, Yuan Wang, Zhenyu Wang, Di Liu & Feng Hong. (2022) Prevalence of Helicobacter pylori in Non-Cardia Gastric Cancer in China: A Systematic Review and Meta-Analysis. Frontiers in Oncology 12.
Crossref
Crossref
Peipei Gao, Ning Cai, Xiaorong Yang, Ziyu Yuan, Tiejun Zhang, Ming Lu, Li Jin, Weimin Ye, Chen Suo & Xingdong Chen. (2021)
Association of
Helicobacter pylori
and gastric atrophy with adenocarcinoma of the esophagogastric junction in Taixing, China
. International Journal of Cancer 150:2, pages 243-252.
Crossref
Crossref
Alexandre Corthay & Guttorm Haraldsen. 2022. Biomarkers of the Tumor Microenvironment. Biomarkers of the Tumor Microenvironment
195
205
.
Anne Hoffmann, Hans-Michael Behrens, Steffen Heckl, Sandra Krüger, Thomas Becker & Christoph Röcken. (2021) Neoadjuvant/Perioperative Treatment Affects Spatial Distribution and Densities of Tumor Associated Neutrophils and CD8+ Lymphocytes in Gastric Cancer. Journal of Personalized Medicine 11:11, pages 1184.
Crossref
Crossref
Jennifer B. Permuth, Shams RahmanDung-Tsa ChenTim WaterboerAnna R. Giuliano. (2021)
A Case Control Study of the Seroprevalence of
Helicobacter pylori
Proteins and Their Association with Pancreatic Cancer Risk
. Journal of Pancreatic Cancer 7:1, pages 57-64.
Crossref
Crossref
Vasiliy Ivanovich Reshetnyak, Alexandr Igorevich Burmistrov & Igor Veniaminovich Maev. (2021)
Helicobacter pylori
: Commensal, symbiont or pathogen?
. World Journal of Gastroenterology 27:7, pages 545-560.
Crossref
Crossref
Shailja C. Shah, Meg McKinley, Samir Gupta, Richard M. PeekJr.Jr., Maria Elena Martinez & Scarlett L. Gomez. (2020) Population-Based Analysis of Differences in Gastric Cancer Incidence Among Races and Ethnicities in Individuals Age 50 Years and Older. Gastroenterology 159:5, pages 1705-1714.e2.
Crossref
Crossref
Ruijing Yan, Yi Guo, Qingyun Gong, Man Chen, Yuanning Guo, Peng Yang, Hao Huang, Haihua Huang, Wen Huang, Zikai Ma, Zhijian Zheng, Dongping Tian & Min Su. (2020) Microbiological evidences for gastric cardiac microflora dysbiosis inducing the progression of inflammation. Journal of Gastroenterology and Hepatology 35:6, pages 1032-1041.
Crossref
Crossref
Shria KumarDavid C. MetzDavid E. KaplanDavid S. Goldberg. (2020) Treatment of Helicobacter pylori Is Not Associated With Future Clostridium difficile Infection. American Journal of Gastroenterology 115:5, pages 716-722.
Crossref
Crossref
Shria Kumar, David C. Metz, Gregory G. Ginsberg, David E. Kaplan & David S. Goldberg. (2020)
Oesophageal and proximal gastric adenocarcinomas are rare after detection of
Helicobacter pylori
infection
. Alimentary Pharmacology & Therapeutics 51:8, pages 781-788.
Crossref
Crossref
Shuanghua Xie, Shaoming Wang, Liyan Xue, Daniel R. S. Middleton, Chentao Guan, Changqing Hao, Jinwu Wang, Bianyun Li, Ru Chen, Xinqing Li & Wenqiang Wei. (2020) Helicobacter pylori Is Associated With Precancerous and Cancerous Lesions of the Gastric Cardia Mucosa: Results of a Large Population-Based Study in China. Frontiers in Oncology 10.
Crossref
Crossref
Karen Basen-Engquist, Powel Brown, Adriana M. Coletta, Michelle Savage, Karen Colbert Maresso & Ernest Hawk. 2020. Abeloff's Clinical Oncology. Abeloff's Clinical Oncology
337
374.e12
.
Fatima Ezzahra Rihane, Najwa Hassou, Sellama Nadifi & Moulay Mustapha Ennaji. 2020. Emerging and Reemerging Viral Pathogens. Emerging and Reemerging Viral Pathogens
571
585
.
Seyedeh Zahra Bakhti, Saeid Latifi‐Navid, Saber Zahri & Abbas Yazdanbod. (2019)
Inverse association of
Helicobacter pylori cag
PAI genotypes with risk of cardia and non‐cardia gastric adenocarcinoma
. Cancer Medicine 8:10, pages 4928-4937.
Crossref
Crossref
Santhosh P. V, Ravindran Chirukandath, Geethanjali M.Vinodh M.. (2019) PREVALENCE OF HELICOBACTER PYLORI INFECTION IN GASTRIC CANCER IN PATIENTS ATTENDING A TERTIARY REFERRAL UNIT: A CROSS SECTIONAL STUDY. Journal of Evidence Based Medicine and Healthcare 6:22, pages 1589-1592.
Crossref
Crossref
Hanseul Kim, NaNa Keum, Edward L. Giovannucci, Charles S. Fuchs & Ying Bao. (2018) Garlic intake and gastric cancer risk: Results from two large prospective US cohort studies. International Journal of Cancer 143:5, pages 1047-1053.
Crossref
Crossref
Seyedeh Zahra Bakhti, Saeid Latifi-Navid, Saber Zahri, Fatemeh Sadat Bakhti, Naser Hajavi & Abbas Yazdanbod. (2017) Are Helicobacter pylori highly cytotoxic genotypes and cardia gastric adenocarcinoma linked? Lessons from Iran. Cancer Biomarkers 21:1, pages 235-246.
Crossref
Crossref
Ali Shahriari-Ahmadi, Neda Shalbaf, Mohsen Masoodi, Maryam Shalbaf, Vida Bozorgi & Masoud Sadeghi. (2017) Endoscopic and Colonoscopic Findings in Patients with Iron Deficiency Anemia: The Risk of Cancer. International Journal of Cancer Management 10:10.
Crossref
Crossref
Dan Li, Chuancheng Wu, Yuanhua Cai & Baoying Liu. (2017)
Association of
NFKB1
and
NFKBIA
gene polymorphisms with susceptibility of gastric cancer
. Tumor Biology 39:7, pages 101042831771710.
Crossref
Crossref
Matthew C. B. Tsilimigras, Anthony Fodor & Christian Jobin. (2017) Carcinogenesis and therapeutics: the microbiota perspective. Nature Microbiology 2:3.
Crossref
Crossref
Shyam Singh & Hem Chandra Jha. (2017)
Status of Epstein-Barr Virus Coinfection with
Helicobacter pylori
in Gastric Cancer
. Journal of Oncology 2017, pages 1-17.
Crossref
Crossref
Alexandre Corthay & Guttorm Haraldsen. 2017. Biomarkers of the Tumor Microenvironment. Biomarkers of the Tumor Microenvironment
241
257
.
Xianlong Ling, Haoxiang Zhang, Caifei Shen, Wu Yan, Pu Wang, Ji Feng, Zhihong Peng, Guiyong Peng, Wensheng Chen & Dianchun Fang. (2016) H. pylori infection is related to mitochondrial microsatellite instability in gastric carcinogenesis. Infectious Agents and Cancer 11:1.
Crossref
Crossref
Yoku Hayakawa, Nilay Sethi, Antonia R. Sepulveda, Adam J. Bass & Timothy C. Wang. (2016) Oesophageal adenocarcinoma and gastric cancer: should we mind the gap?. Nature Reviews Cancer 16:5, pages 305-318.
Crossref
Crossref
Jyh-Ming Liou, Jaw-Town Lin & Ming-Shiang Wu. 2016. Helicobacter pylori. Helicobacter pylori
181
202
.
Karen Colbert Maresso, Kenneth Y. Tsai, Powel H. Brown, Eva Szabo, Scott Lippman & Ernest T. Hawk. (2015) Molecular cancer prevention: Current status and future directions. CA: A Cancer Journal for Clinicians 65:5, pages 345-383.
Crossref
Crossref
Jan Bornschein, Andrea Dingwerth, Michael Selgrad, Marino Venerito, Patrick Stuebs, Katrin Frauenschlaeger, Achilleas Achilleos, Albert Roessner & Peter Malfertheiner. (2015) Adenocarcinomas at different positions at the gastro-oesophageal junction show distinct association with gastritis and gastric preneoplastic conditions. European Journal of Gastroenterology & Hepatology 27:5, pages 492-500.
Crossref
Crossref
Saleh Al-Othman, Abdelali Haoudi, Samar Alhomoud, Abdullah Alkhenizan, Tawfik Khoja & Ali Al-Zahrani. (2015) Tackling cancer control in the Gulf Cooperation Council Countries. The Lancet Oncology 16:5, pages e246-e257.
Crossref
Crossref
Noman AshrafSarah Hoffe & Richard Kim. (2015) Locally Advanced Gastroesophageal Junction Tumor: A Treatment Dilemma. The Oncologist 20:2, pages 134-142.
Crossref
Crossref
R. Ntagirabiri, S. Harerimana, F. Makuraza, E. Ndirahisha, H. Kaze & A. Moibeni. (2014) Helicobacter pylori au Burundi : première évaluation de la prévalence en endoscopie et de l’éradicationHelicobacter pylori in Burundi: first assessment of prevalence in endoscopy and eradication. Journal Africain d'Hépato-Gastroentérologie 8:4, pages 217-222.
Crossref
Crossref
Ibrahim Halil Sahin, Manal M. Hassan & Christopher R. Garrett. (2014) Impact of non-steroidal anti-inflammatory drugs on gastrointestinal cancers: Current state-of-the science. Cancer Letters 345:2, pages 249-257.
Crossref
Crossref
Derrick Siao & Ma Somsouk. (2013) Helicobacter pylori: Evidence-Based Review with a Focus on Immigrant Populations. Journal of General Internal Medicine 29:3, pages 520-528.
Crossref
Crossref
Grigorios I. Leontiadis & Olof Nyrén. 2014. GI Epidemiology. GI Epidemiology
135
157
.
B. Deng, Y. Li, Y. Zhang, L. Bai & P. Yang. (2013) Helicobacter pylori infection and lung cancer: a review of an emerging hypothesis. Carcinogenesis 34:6, pages 1189-1195.
Crossref
Crossref
Victoria P.Y. Tan & Benjamin C.Y. Wong. (2013) Gastric Cancer Chemoprevention. Gastroenterology Clinics of North America 42:2, pages 299-316.
Crossref
Crossref
Astri L. Larsen, Eivind Ragnhildstveit, Berouz Moayeri, Lisbeth Eliassen & Kjetil K. Melby. (2012)
Resistance rates of metronidazole and other antibacterials in
H
elicobacter pylori
from previously untreated patients in
N
orway
. APMIS 121:4, pages 353-358.
Crossref
Crossref
Michael B. Cook, Farin Kamangar, Stephanie J. Weinstein, Demetrius Albanes, Jarmo Virtamo, Philip R. Taylor, Christian C. Abnet, Richard J. Wood, Gayle Petty, Amanda J. Cross & Sanford M. Dawsey. (2012) Iron in Relation to Gastric Cancer in the Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study. Cancer Epidemiology, Biomarkers & Prevention 21:11, pages 2033-2042.
Crossref
Crossref
Hyuk Yoon, Nayoung Kim, Hye Seung Lee, Cheol Min Shin, Young Soo Park, Dong Ho Lee, Do Joong Park, Hyung Ho Kim & Hyun Chae Jung. (2012) Effect of endoscopic screening at 1‐year intervals on the clinicopathologic characteristics and treatment of gastric cancer in South Korea. Journal of Gastroenterology and Hepatology 27:5, pages 928-934.
Crossref
Crossref
Menachem Moshkowitz. (2012)
Gender-associated differences in urea breath test for
Helicobacter pylori
infection referrals and results among dyspeptic patients
. World Journal of Gastrointestinal Pathophysiology 3:3, pages 80.
Crossref
Crossref
Michael Selgrad, Jan Bornschein, Jochen Weigt & Peter Malfertheiner. (2012) Molekulare Grundlagen und Pathomechanismen des Karzinoms am ösophagogastralen Übergang. Viszeralmedizin 28:2, pages 96-102.
Crossref
Crossref
Alexander C. Ford. (2011) Chemoprevention for gastric cancer. Best Practice & Research Clinical Gastroenterology 25:4-5, pages 581-592.
Crossref
Crossref
Marlene Cavaleiro-Pinto, Bárbara Peleteiro, Nuno Lunet & Henrique Barros. (2010) Helicobacter pylori infection and gastric cardia cancer: systematic review and meta-analysis. Cancer Causes & Control 22:3, pages 375-387.
Crossref
Crossref
Bárbara Peleteiro, Nuno Lunet, Rita Barros, Carlo La Vecchia & Henrique Barros. (2010) Factors contributing to the underestimation of Helicobacter pylori-associated gastric cancer risk in a high-prevalence population. Cancer Causes & Control 21:8, pages 1257-1264.
Crossref
Crossref
Kenneth E.L. McColl. (2010)
Helicobacter pylori
Infection
. New England Journal of Medicine 362:17, pages 1597-1604.
Crossref
Crossref
Giuseppe La Torre, Giacomina Chiaradia, Francesco Gianfagna, Angelo De Lauretis, Stefania Boccia, Alice Mannocci & Walter Ricciardi. (2018) Smoking Status and Gastric Cancer Risk: An Updated Meta-Analysis of Case-Control Studies Published in the past Ten Years. Tumori Journal 95:1, pages 13-22.
Crossref
Crossref
Margarita Camorlinga-Ponce, Lourdes Flores-Luna, Eduardo Lazcano-Ponce, Rolando Herrero, Fernando Bernal-Sahagún, Juan Miguel Abdo-Francis, Jesús Aguirre-García, Nubia Muñoz & Javier Torres. (2008)
Age and Severity of Mucosal Lesions Influence the Performance of Serologic Markers in
Helicobacter pylori
–Associated Gastroduodenal Pathologies
. Cancer Epidemiology, Biomarkers & Prevention 17:9, pages 2498-2504.
Crossref
Crossref
C. Kurkjian, S. Kummar & A.J. Murgo. (2008) DNA Methylation: Its Role in Cancer Development and Therapy. Current Problems in Cancer 32:5, pages 187-235.
Crossref
Crossref
Ricardo Ladeiras-Lopes, Alexandre Kirchhofer Pereira, Amanda Nogueira, Tiago Pinheiro-Torres, Isabel Pinto, Ricardo Santos-Pereira & Nuno Lunet. (2008) Smoking and gastric cancer: systematic review and meta-analysis of cohort studies. Cancer Causes & Control 19:7, pages 689-701.
Crossref
Crossref
Kwong Ming Fock, Nick Talley, Paul Moayyedi, Richard Hunt, Takeshi Azuma, Kentaro Sugano, Shu Dong Xiao, Shiu Kum Lam, Khean Lee Goh, Tsutomu Chiba, Naomi Uemura, Jae G Kim, Nayoung Kim, Tiing Leong Ang, Varocha Mahachai, Hazel Mitchell, Abdul Aziz Rani, Jyh Ming Liou, Ratha‐korn Vilaichone & Jose Sollano. (2008) Asia–Pacific consensus guidelines on gastric cancer prevention. Journal of Gastroenterology and Hepatology 23:3, pages 351-365.
Crossref
Crossref
Tetsuo Hirata, Manabu Nakamoto, Masamoto Nakamura, Nagisa Kinjo, Akira Hokama, Fukunori Kinjo & Jiro Fujita. (2007) Low prevalence of human T cell lymphotropic virus type 1 infection in patients with gastric cancer. Journal of Gastroenterology and Hepatology 22:12, pages 2238-2241.
Crossref
Crossref
Nao Yoshizawa, Yoshiharu Takenaka, Hirokazu Yamaguchi, Tsukamoto Tetsuya, Harunari Tanaka, Masae Tatematsu, Sachiyo Nomura, James R Goldenring & Michio Kaminishi. (2007) Emergence of spasmolytic polypeptide-expressing metaplasia in Mongolian gerbils infected with Helicobacter pylori. Laboratory Investigation 87:12, pages 1265-1276.
Crossref
Crossref
Olof Nyrén. 2007. GI Epidemiology. GI Epidemiology
124
142
.
M van Blankenstein, C W N Looman, P D Siersema, E J Kuipers & J W W Coebergh. (2007) Trends in the incidence of adenocarcinoma of the oesophagus and cardia in the Netherlands 1989–2003. British Journal of Cancer 96:11, pages 1767-1771.
Crossref
Crossref
Domenico Palli, Giovanna Masala, Giuseppe Del Giudice, Mario Plebani, Daniela Basso, Duccio Berti, Mattijs E. Numans, Marco Ceroti, Petra H.M. Peeters, H. Bas Bueno de Mesquita, Frederike L. Buchner, Francoise Clavel‐Chapelon, Marie‐Christine Boutron‐Ruault, Vittorio Krogh, Calogero Saieva, Paolo Vineis, Salvatore Panico, Rosario Tumino, Olof Nyrén, Henrik Simán, Goran Berglund, Goran Hallmans, Maria‐Jose Sanchez, Nerea Larrãnaga, Aurelio Barricarte, Carmen Navarro, Jose R. Quiros, Tim Key, Naomi Allen, Sheila Bingham, Kay Tee Khaw, Heiner Boeing, Cornelia Weikert, Jakob Linseisen, Gabriele Nagel, Kim Overvad, Reimar W. Thomsen, Anne Tjonneland, Anja Olsen, Antonia Trichoupoulou, Dimitrios Trichopoulos, Athina Arvaniti, Guillem Pera, Rudolf Kaaks, Mazda Jenab, Pietro Ferrari, Gabriella Nesi, Fatima Carneiro, Elio Riboli & Carlos A. Gonzalez. (2006)
CagA+
Helicobacter pylori
infection and gastric cancer risk in the EPIC‐EURGAST study
. International Journal of Cancer 120:4, pages 859-867.
Crossref
Crossref
L. FUCCIO, R. M. ZAGARI, M. E. MINARDI & F. BAZZOLI. (2006)
Systematic review:
Helicobacter pylori
eradication for the prevention of gastric cancer
. Alimentary Pharmacology & Therapeutics 25:2, pages 133-141.
Crossref
Crossref
F Kamangar, Y-L Qiao, M J Blaser, X-D Sun, H Katki, J-H Fan, G I Perez-Perez, C C Abnet, P Zhao, S D Mark, P R Taylor & S M Dawsey. (2006) Helicobacter pylori and oesophageal and gastric cancers in a prospective study in China. British Journal of Cancer 96:1, pages 172-176.
Crossref
Crossref
De-Chuan Chan, Cheng-Jueng Chen, Heng-Cheng Chu, Wei-Kuo Chang, Jyh-Cherng Yu, Yu-Ju Chen, Li-Li Wen, Su-Ching Huang, Chih-Hung Ku, Yao-Chi Liu & Jenn-Han Chen. (2006) Evaluation of Serum Amyloid A as a Biomarker for Gastric Cancer. Annals of Surgical Oncology 14:1, pages 84-93.
Crossref
Crossref
Olof Nyrén & William J. Blot. (2006) Helicobacter pylori Infection: Mainly Foe but Also Friend?. JNCI: Journal of the National Cancer Institute 98:20, pages 1432-1434.
Crossref
Crossref
Farin Kamangar, Sanford M. Dawsey, Martin J. Blaser, Guillermo I. Perez-Perez, Pirjo Pietinen, Craig J. Newschaffer, Christian C. Abnet, Demetrius Albanes, Jarmo Virtamo & Philip R. Taylor. (2006) Opposing Risks of Gastric Cardia and Noncardia Gastric Adenocarcinomas Associated With Helicobacter pylori Seropositivity. JNCI: Journal of the National Cancer Institute 98:20, pages 1445-1452.
Crossref
Crossref
Christian Schumann, Kathy Triantafilou, F. Maximilian Rasche, Angelika Möricke, Konstanze Vogt, Martha Triantafilou, Philipp Hahn, E. Marion Schneider & Philipp M. Lepper. (2006) Serum antibody positivity for distinct Helicobacter pylori antigens in benign and malignant gastroduodenal disease. International Journal of Medical Microbiology 296:4-5, pages 223-228.
Crossref
Crossref
Shizuka Sasazuki, Manami Inoue, Motoki Iwasaki, Tetsuya Otani, Seiichiro Yamamoto, Shinobu Ikeda, Tomoyuki Hanaoka & Shoichiro Tsugane. (2006)
Effect of
Helicobacter pylori
Infection Combined with CagA and Pepsinogen Status on Gastric Cancer Development among Japanese Men and Women: A Nested Case-Control Study
. Cancer Epidemiology, Biomarkers & Prevention 15:7, pages 1341-1347.
Crossref
Crossref
Vanessa Blair, Iain Martin, David Shaw, Ingrid Winship, Dale Kerr, Julie Arnold, Pauline Harawira, Maybelle McLeod, Susan Parry, Amanda Charlton, Michael Findlay, Brian Cox, Bostjan Humar, Helen More & Parry Guilford. (2006) Hereditary Diffuse Gastric Cancer: Diagnosis and Management. Clinical Gastroenterology and Hepatology 4:3, pages 262-275.
Crossref
Crossref
Tomasz Brzozowski, Peter C. Konturek, Marzena Mierzwa, Danuta Drozdowicz, Wladyslaw Bielanski, Slawomir Kwiecien, Stanislaw J. Konturek, Jerzy Stachura, Wieslaw W. Pawlik & Eckhart G. Hahn. (2006)
Effect of Probiotics and Triple Eradication Therapy on the Cyclooxygenase (COX)‐2 Expression, Apoptosis, and Functional Gastric Mucosal Impairment in
Helicobacter pylori
‐Infected Mongolian Gerbils
. Helicobacter 11:1, pages 10-20.
Crossref
Crossref
Francia Campos. (2006) Risk factors of gastric cancer specific for tumor location and histology in Cali, Colombia. World Journal of Gastroenterology 12:36, pages 5772.
Crossref
Crossref
Katherine D Crew & Alfred I Neugut. (2006) Epidemiology of gastric cancer. World Journal of Gastroenterology 12:3, pages 354.
Crossref
Crossref
H. J. Meyer. 2006. Pichlmayrs Chirurgische Therapie. Pichlmayrs Chirurgische Therapie
235
295
.
Peter Malfertheiner, Pentti Sipponen, Michael Naumann, Paul Moayyedi, Francis Megraud, Shu-Dong Xiao, Kentaro Sugano & Olof Nyren. (2005) Helicobacter pylori Eradication Has the Potential to Prevent Gastric Cancer: A State-of-the-Art Critique. The American Journal of Gastroenterology 100:9, pages 2100-2115.
Crossref
Crossref
Ylva Tindberg, Olof Nyrén, Margareta Blennow & Marta Granström. (2005)
Helicobacter pylori
Infection and Abdominal Symptoms Among Swedish School Children
. Journal of Pediatric Gastroenterology and Nutrition 41:1, pages 33-38.
Crossref
Crossref
Daiva Janulaityte-Günther, Limas Kupcinskas, Alvydas Pavilonis, Konstantinas Valuckas, Leif Percival Andersen & Torkel Wadström. (2005)
Helicobacter pylori
antibodies and gastric cancer: a gender-related difference
. FEMS Immunology & Medical Microbiology 44:2, pages 191-195.
Crossref
Crossref
K. E. L. McColl. (2004)
Review article:
Helicobacter pylori
and gastro‐oesophageal reflux disease − the European perspective
. Alimentary Pharmacology & Therapeutics 20:s8, pages 36-39.
Crossref
Crossref
Nuno Lunet & Henrique Barros. (2003)
Helicobacter pylori
infection and gastric cancer: Facing the enigmas
. International Journal of Cancer 106:6, pages 953-960.
Crossref
Crossref
David Forman, Simon Everett & Paul Moayyedi. 2003. Evidence‐based Oncology. Evidence‐based Oncology
172
187
.
Audun Berstad & Per Brandtzaeg. 2003. International Handbook of Foodborne Pathogens. International Handbook of Foodborne Pathogens.
Anna H. Wu, Jean E. Crabtree, Leslie Bernstein, Peter Hawtin, Myles Cockburn, Chiu‐chen Tseng & David Forman. (2002)
Role of
Helicobacter pylori
CagA+ strains and risk of adenocarcinoma of the stomach and esophagus
. International Journal of Cancer 103:6, pages 815-821.
Crossref
Crossref
Yong-Li Yang. (2003)
Overexpression of c-fos in
Helicobacter pylori
-induced gastric precancerosis of Mongolian gerbil
. World Journal of Gastroenterology 9:3, pages 521.
Crossref
Crossref
Lin Cai. (2003) Risk factors for the gastric cardia cancer: a case-control study in Fujian Province. World Journal of Gastroenterology 9:2, pages 214.
Crossref
Crossref
N L A Arents, J C Thijs & J H Kleibeuker. (2002) A rational approach to uninvestigated dyspepsia in primary care: review of the literature. Postgraduate Medical Journal 78:926, pages 707-716.
Crossref
Crossref
Kjell K. Øvrebø, Steinar Aase, Ketil Grong, Asgaut Viste, Knut Svanes & Halfdan Sørbye. (2002) Ulceration as a Possible Link between Duodenogastric Reflux and Neoplasms in the Stomach of Rats. Journal of Surgical Research 107:2, pages 167-178.
Crossref
Crossref
Ann Chao, Michael J. Thun, S. Jane Henley, Eric J. Jacobs, Marjorie L. McCullough & Eugenia E. Calle. (2002) Cigarette smoking, use of other tobacco products and stomach cancer mortality in US adults: The Cancer Prevention Study II. International Journal of Cancer 101:4, pages 380-389.
Crossref
Crossref
Tae Jung Jang, Nam Il Kim, Jeong Ill Suh & Chang Heon Yang. (2002)
Reflux esophagitis facilitates low
Helicobacter pylori
infection rate and gastric inflammation
. Journal of Gastroenterology and Hepatology 17:8, pages 839-843.
Crossref
Crossref
P. Malfertheiner, J. Dent, L. Zeijlon, P. Sipponen, S. J. O. Veldhuyzen Van Zanten, C.‐F. Burman, T Lind, M Wrangstadh, E BayerdÖrffer & J Lonovics. (2002)
Impact of
Helicobacter pylori
eradication on heartburn in patients with gastric or duodenal ulcer disease — results from a randomized trial programme
. Alimentary Pharmacology & Therapeutics 16:8, pages 1431-1442.
Crossref
Crossref
Run-Tian Wang. (2002)
Helicobacter pylori
infection and gastric cancer: evidence from a retrospective cohort study and nested case-control study in China
. World Journal of Gastroenterology 8:6, pages 1103.
Crossref
Crossref
Yong-Li Yao. (2002)
Overexpression of cyclin E in Mongolian gerbil with
Helicobacter pylori-
induced gastric precancerosis
. World Journal of Gastroenterology 8:1, pages 60.
Crossref
Crossref
Gareth S. Dulai, Sushovan Guha, Katherine L. Kahn, Jeffrey Gornbein & Wilfred M. Weinstein. (2002) Preoperative prevalence of Barrett's esophagus in esophageal adenocarcinoma: A systematic review. Gastroenterology 122:1, pages 26-33.
Crossref
Crossref
Javier P. Gisbert & José María Pajares. (2002) Prevalencia de la infección por Helicobacter pylori en la enfermedad por reflujo gastroesofágico y en el esófago de Barrett: revisión sistemática y metaanálisis. Medicina Clínica 119:6, pages 217-223.
Crossref
Crossref
Takahiro Fujimori, Hitoshi Kawamata, Kazuhito Ichikawa, Yuko Ono, Yasuo Okura, Shigeki Tomita & Johji Imura. (2002) Pathological issues of gastric and lower esophageal cancer:Helicobacter pylori infection and its eradication. Journal of Gastroenterology 37:S13, pages 28-33.
Crossref
Crossref
M. Robaszkiewicz. (2001) Épidémiologie des adénocarcinomes de l’œsophage et de la jonction œsogastrique. Cancer/Radiothérapie 5, pages 78s-79s.
Crossref
Crossref
Jonathan M. Rieber, Elizabeth H. Weinshel, Tan Nguyen, Gurdip S. Sidhu & Edmund J. Bini. (2001) Synchronous Gastric Adenocarcinomas in a Patient With Meckel's Diverticulum. Journal of Clinical Gastroenterology 33:1, pages 78-80.
Crossref
Crossref
R.A. Feldman. (2001) Would eradication of Helicobacter pylori infection reduce the risk of gastric cancer?. Alimentary Pharmacology & Therapeutics 15:s1, pages 2-5.
Crossref
Crossref
P. J. Limburg, Y.-L. Qiao, S. D. Mark, G.-Q. Wang, G. I. Perez-Perez, M. J. Blaser, Y.-P. Wu, X.-N. Zou, Z.-W. Dong, P. R. Taylor & S. M. Dawsey. (2001) Helicobacter pylori Seropositivity and Subsite-Specific Gastric Cancer Risks in Linxian, China. JNCI Journal of the National Cancer Institute 93:3, pages 226-233.
Crossref
Crossref
A. Cats & E. J. Kuipers. 2001. Barrett’s Esophagus. Barrett’s Esophagus
81
105
.
A. T. R. Axon. (2002) Treatment of Helicobacter pylori: an overview. Alimentary Pharmacology & Therapeutics 14:s3, pages 1-6.
Crossref
Crossref
Hession & Malagelada. (2001) Review article: the initial management of uninvestigated dyspepsia in younger patients—the value of symptom‐guided strategies should be reconsidered. Alimentary Pharmacology & Therapeutics 14:4, pages 379-388.
Crossref
Crossref
W. M. Weinstein. 2000. Helicobacter pylori. Helicobacter pylori
299
306
.